Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
- Update frequency
- every 5 days
- Episodes
- 347
- Years Active
- 2015 - 2025
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Between 20 and 50 percent of patients with high-risk localized prostate cancer will develop biochemical resistance, but historically, no Level I evidence for trea…
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
The National Comprehensive Cancer Network (NCCN) has recommended new guidelines for the treatment of prostate Cancer. In this episode, you’ll learn about …
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Between 20 and 50 percent of patients with high-risk localized prostate cancer will develop biochemical resistance, but historically, no Level I evidence for trea…
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Guest: Liza Villaruz, MD
According to a recent study, the immune checkpoint inhibitor durvalumab is not only considered safe, but it may also offer overall surviva…
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Guest: Liza Villaruz, MD
According to a recent study, the immune checkpoint inhibitor durvalumab is not only considered safe, but it may also offer overall surviva…
Inflammatory Breast Cancer: A New Scoring System Proposed
Inflammatory breast cancer (IBC) is a rare disease that represents about two to three percent of all breast cancers and is challenging to diagnose. To improve diagno…
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
It’s very common for patients with inflammatory breast cancer (IBC) to present with no underlying palpable mass, which may cause some challenges for clinicians and p…
Inflammatory Breast Cancer: A New Scoring System Proposed
Inflammatory breast cancer (IBC) is a rare disease that represents about two to three percent of all breast cancers and is challenging to diagnose. To improve diagno…
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
It’s very common for patients with inflammatory breast cancer (IBC) to present with no underlying palpable mass, which may cause some challenges for clinicians and p…
A Look at What’s New in Invasive Lobular Carcinoma
Guest: Jason A. Mouabbi, MD
Invasive lobular carcinoma (ILC) is an understudied subtype that occurs in about 10 to 15 percent of breast cancer patients a…
A Look at What’s New in Invasive Lobular Carcinoma
Guest: Jason A. Mouabbi, MD
Invasive lobular carcinoma (ILC) is an understudied subtype that occurs in about 10 to 15 percent of breast cancer patients a…
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Guest: Jose Pablo Leone, MD
Breast cancer is the second most common cause of brain metastases. Given this prevalence, how can we identify the early signs…
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Guest: Jose Pablo Leone, MD
Breast cancer is the second most common cause of brain metastases. Given this prevalence, how can we identify the early signs…
Examining the Economic Impacts of Biosimilars in Oncology
Guest: Sophia Humphreys, PharmD, MHA, BCBBS
Not only can biosimilars impact the health of our patients with cancer, but they can al…
Examining the Economic Impacts of Biosimilars in Oncology
Guest: Sophia Humphreys, PharmD, MHA, BCBBS
Not only can biosimilars impact the health of our patients with cancer, but they can al…
Approaches to Utilizing Bone-targeting Therapies in mBC
Guest: Gabriel N. Hortobagyi, MD
Bone metastases are the most frequent site of metastatic spread for breast cancer, especially for the luminal subtypes, …
Approaches to Utilizing Bone-targeting Therapies in mBC
Guest: Gabriel N. Hortobagyi, MD
Bone metastases are the most frequent site of metastatic spread for breast cancer, especially for the luminal subtypes, …
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Guest: Nick McAndrew, MD, MSCE
How can ribociclib plus endocrine therapy help reduce recurrence in early breast cancer? That’s the exact question the NAT…
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Guest: Nick McAndrew, MD, MSCE
How can ribociclib plus endocrine therapy help reduce recurrence in early breast cancer? That’s the exact question the NAT…
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Guest: Jia Luo, MD
NUT carcinoma is a rare, aggressive form of cancer that’s highly resistant to therapy and has no defined standard treatment. Joining Dr. Jacob S…